Found 4 matching trials
3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study PHASE3 Follow-up for viral activity, changes in liver function and safety in patie...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option PHASE2 The primary purpose of this study is to evaluate the pharmacodynamic (i.e. ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment PHASE2 The study is to investigate whether participants with hepatitis C virus (HC...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1 PHASE3 This study will assess the safety and efficacy of alisporivir (ALV) and boc...
Show More Location
Novartis Investigational Site
Learn More & Join Trial